Frazier Life Sciences
Announced 31 Jul 2025$1.3B · fund · Financial Services · United States
Frazier Life Sciences invests globally in private and publicly-traded companies that discover, develop, and commercialize innovative biopharmaceuticals.
“Frazier Life Sciences raises $1.3B for early-stage biotech fund Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthal”
3 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →Investors: longstanding and new limited partners.